Pharmacists have warned that the shortage of new new normal medicine is now for patients and pose a significant risk to general health.
A new report from the British Society Pharmacy (CPE), which shows more than 10,000 community pharmacies, emphasized the “unprecedented” topics that patients face due to lack of drugs.
The poll, which voted for more than 4,300 pharmacy owners and 1,600 pharmacy workers across the UK, showed that this is worse than when a similar assessment was done three years ago.
Found:
- About 95 percent of pharmacy workers said patients are still upset with constant shortage, while 73 percent said it would endanger patient health problems.
- Many of them face disappointing patients and report 79 % of patient aggression reports that the drugs were unavailable or delayed.
- About 86 percent of pharmacy owners said deficiencies would make patients visit multiple pharmacies in search of medicines.
- Looking for medicines for employees, so that 39 % of pharmacy employees are now spending one to two hours every day trying to take medication, with more than a quarter (26 %) spent more than two hours.
- Approximately half (49 %) of pharmacy owners said that the patient’s services were affected by the stress on their business, and 94 % directly linked to medical supply problems.
The British Society Pharmacy said that in the past year, the government has replaced serious deficiency protocols (SSPs) for the key drugs used in the treatment of schizophrenia, bipolar disorder, angina, HRT, antibiotics such as sycontinexine and clarithromycin and drugs related to cardiovascular and enzymes.
According to him, there is also a shortage of drugs for ADHD, diabetes and epilepsy.
SSPs occur to identify alternative or quantitative drugs that may be prepared if the drug is removed.
“Our study shows that because medical issues remain a daily reality throughout the country, the risk of patient health has become a new distressing natural nature,” said Janet Morrison, executive director of the British Society.
Delay in taking drugs not only disrupts the treatment of patients but can also cause unnecessary stress and potential damage to their health.
“The time and effort needed to manage the deficiency, as well as the pressure on the pharmaceutical teams, which are currently working in full stretch, adds,” he said.
“Our survey results show a trapped system that is stuck at the point of breaking.”
He said these problems are due to issues related to product cuts to the challenges of the global supply chain.
“We also believe that the price of low drug in the UK has made the market less attractive to producers and weakens the supply system resistance,” he said.
“The future is unclear, with the inflation of drug prices and the possible effects of beatings throughout the NHS, but we welcome the government’s commitment to continuous work to reduce the supply chain resistance and monitor the situation.”
Compared to 2022, 2025 has worsened in the study, with 51 % of pharmaceutical teams in 2022 say patients are affected by supply and increased to 73 percent in 2025.
There were also more supply issues, while teams are more likely to arrange them.
“This is not just a matter of disappearance: patients are desperately disappointed and harm their health,” said Fin McCell, a community pharmacy owner in the Great Manchester.
“Our teams are in the middle and spend hours to contact suppliers and call GPS and try to find other options, while trying to keep patients aware,” he said.
“Continuous uncertainty affects our employees and patients, and every year it only looks worse.”
However, a Healthwatch England survey of more than 7,000 adults, four of which continue to report on medical shortages, while issues such as delay in the prescription, pharmacy closure and reasonable prices are on the rise.
About 18 % of the errors reported, 5 % worried about costs and 9 % of unexpected pharmacy reports.
The poll also suggests that people are not always aware of the conditions that pharmacists can be aware of to avoid traveling to a physician.
“This government has inherited global supply problems, but we have strong steps to reduce patient disorder,” said a spokesman for the Ministry of Health and Social Care.
“We are trying to build resistance to medical supply chains and prevent future disruption because we return the NHS on its feet,” he said.
“We have recently agreed with the British Pharmacy to help community pharmacies, to help community pharmacies, support this sector, and provide more home services, with the British community pharmacy,” he said.
“Intentional violence or abuse of health care staff is unacceptable and all employees, including pharmacists and their teams, deserve to work in a safe and safe environment.”
